Dexcom (DXCM) Cash & Equivalents Growth (1y) (2011 - 2026)
Dexcom (DXCM) Cash & Equivalents Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 4.15% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 24.05% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -7.50% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 100.41% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -22.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 20.15% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 23.57% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -7.71% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 156.03% |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | -69.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.57% |
| Dec 31, 2025 | 192.70% |
| Sep 30, 2025 | 121.06% |
| Jun 30, 2025 | -35.06% |
| Mar 31, 2025 | 6.31% |
| Dec 31, 2024 | -76.30% |
| Sep 30, 2024 | -3.50% |
| Jun 30, 2024 | -21.40% |
| Mar 31, 2024 | 36.59% |
| Dec 31, 2023 | -11.83% |
| Sep 30, 2023 | -7.79% |
| Jun 30, 2023 | 62.48% |
| Mar 31, 2023 | -12.96% |
| Dec 31, 2022 | -38.98% |
| Sep 30, 2022 | -51.67% |
| Jun 30, 2022 | -36.54% |
| Mar 31, 2022 | -2.43% |
| Dec 31, 2021 | 28.74% |
| Sep 30, 2021 | 114.45% |
| Jun 30, 2021 | 118.64% |